Positioning no disclosures inside 60 days, left as found
Options put/call open interest 3.97, read 2026-11-01
Ethical does not pass the values gate
Price7.38 USD
Fair value15.94
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-25Read Accumulation8.93-17.4% to today Markdown gives way to Accumulation
2026-10-18Read Markdown8.93-17.4% to today ✓Accumulation gives way to Markdown first Markdown read since October
2026-10-11Read Accumulation8.52-13.4% to today Markdown gives way to Accumulation after a 13% slide in 4 weeks
2026-09-15Read Markdown9.79-24.6% to today ✓Distribution gives way to Markdown after a 21% slide in 11 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Tripadvisor, Inc. holds its Accumulation at $7.38. Consolidating, no directional conviction, held for 32 days.
As held on the ledger · 2026-11-05
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 32 days
Price at the screen
$7.38
Valuation
85.20 trailing · 7.94 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.86
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
47.66%
Below 33%
Interest-bearing debt is 47.7% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
46.29%
Below 49%
Money owed to the company is 46.3% of assets, under the 49% limit.
Pass
Revenue purity
2.12%
Below 5%
Only 2.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Tripadvisor,'s business is in a permissible area, but its interest-bearing debt is about 48% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when TRIP's ethical verdict changes
Today TRIP does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 36% discount to our $15.94 fair value.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 53.7% discount to the base estimate.
Where our models see it going: fair-value estimate $15.94, with a range of $15.94 to $20.40, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Tripadvisor stuck in travel's slow lane
Picture a traveller scrolling Tripadvisor for the perfect tour, only to find the platform itself shrinking. Revenue fell 4 percent last year while the business eked out a 1 percent profit margin and a 3 percent return on equity. Forward earnings trade at 9.2 times yet analysts see almost no upside from the current price, and our screen flags no real opportunity despite clearing the ethical test.
The low multiple reflects a cyclical travel business facing stiffer competition and thin pricing power. Peak-cycle earnings often look cheap on paper, yet they rarely stay elevated once demand normalises. Unknown competitive moat adds another layer of uncertainty around whether margins can expand meaningfully from here.
We therefore pass. The modest margin of safety implied by our fair-value estimate is not enough to offset the weak growth trajectory and modest capital returns. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TRIP trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Accumulation$10.20+8.1%Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Accumulation$9.44+2.4%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Accumulation$9.22+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Accumulation$9.22+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Accumulation$9.22-2.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Accumulation$9.41+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Accumulation$9.41+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Accumulation$9.41+5.4%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation · changed$8.93+0.0%Entry 9
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13.
2026-10-18Markdown · changed$8.93+4.8%Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (15 analysts) rates it hold, with a mean price target of $13.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
